India, U.S. to collaborate on COVID-19 vaccine trials, say U.S. health officials

sfg-2026
ForumIAS LATEST
    1. 5 August | Toppers Wrote 1000 Answers Between Prelims & Mains! | Click Here to Watch →
    2. 5 August | Are you the Average of the 5 People Around You by Mr. Ayush Sinha | Click Here to Watch →
    3. 5 August | First UPSC Mains Don't Chase AIR 1 by Mr Ayush Sinha | Click Here to Watch →

News:India and the U.S have decided to work together on vaccine research and testing for COVID-19 under the Indo-U.S. Vaccine Action Program(VAP).

Facts:

  • The Indo-US Vaccine Action Programme(VAP) is a bilateral programme established in 1987.
  • Aim: To develop and evolve joint R&D projects towards development of safe and efficacious vaccines against some of the major communicable diseases that presently take a large toll in India & USA.
  • Nodal Agencies: U.S. National Institutes of Health, Indian Department of Biotechnology(DBT) and Indian Council of Medical Research(ICMR) along with other partners.

Additional Facts:

Global Vaccine Action Plan(GVAP):

  • It is a framework adopted at the 65th World Health Assembly in 2012 to achieve the vision of the Decade of Vaccines 2011-2020(DoV).
  • Aim: To prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.
Print Friendly and PDF
Blog
Academy
Community